MK-8141结构式
|
常用名 | MK-8141 | 英文名 | MK-8141 |
|---|---|---|---|---|
| CAS号 | 903579-36-2 | 分子量 | 620.60800 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C35H39Cl2N3O3 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
MK-8141用途MK-8141 (ACT-077825) is a novel potent, selective, direct Renin inhibitor for the treatment of cardiovascular disorders.. |
| 英文名 | (1R,5S)-9-Cyclopropyl-7-{4-[2-(2,6-dichloro-4-methylphenoxy)ethox y]phenyl}-3-(2,3-dimethylbenzyl)-3,9-diazabicyclo[3.3.1]non-6-ene -6-carboxamide |
|---|
| 分子式 | C35H39Cl2N3O3 |
|---|---|
| 分子量 | 620.60800 |
| 精确质量 | 619.23700 |
| PSA | 68.03000 |
| LogP | 7.31250 |
|
~%
MK-8141 903579-36-2 |
| 文献：MERCK and CO., INC.; MERCK FROSST CANADA LTD. Patent: WO2008/88690 A2, 2008 ; Location in patent: Page/Page column 22 ; |
![benzyl (1R,5S)-3-benzyl-6-(cyclopropyl(2,3-dimethylbenzyl)carbamoyl)-7-(4-(2-(2,6-dichloro-4-methylphenoxy)ethoxy)phenyl)-3,9-diazabicyclo[3.3.1]non-6-ene-9-carboxylate结构式](https://www.chemsrc.com/caspic/377/1041438-99-6.png)
